Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Kissimmee, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Kissimmee, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Miami, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Pensacola, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Pensacola, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Port Orange, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Port Orange, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Conyers, GA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Conyers, GA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Duluth, GA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Duluth, GA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
New Orleans, LA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Slidell, LA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Slidell, LA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Sunset, LA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Sunset, LA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Columbia, MD
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Columbia, MD
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Edina, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Edina, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Fridley, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Fridley, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigator Site
mi
from
Minneapolis, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigator Site
mi
from
Minneapolis, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigator Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Plymouth, MN
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Henderson, NV
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Henderson, NV
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis
mi
from
New York, NY
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Charlotte, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Cornelius, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Cornelius, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Gastonia, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Gastonia, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Hickory, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Hickory, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
High Point, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
High Point, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Huntersville, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Huntersville, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Winston-Salem, NC
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Cincinnati, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Columbus, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Columbus, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Dublin, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Dublin, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Marion, OH
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Marion, OH
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Medford, OR
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Medford, OR
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis
mi
from
Portland, OR
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Philadelphia, PA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tipton, PA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tipton, PA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Carrollton, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Carrollton, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Channelview, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Channelview, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Fort Worth, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Lampasas, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Lampasas, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
McKinney, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
McKinney, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
New Braunfels, TX
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Salt Lake City, UT
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Newport News, VA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Newport News, VA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Tacoma, WA
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Multiple Locations, AL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Multiple Locations, AL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Multiple Locations, AZ
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Multiple Locations, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Fort Lauderdale, FL
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated:  11/30/2017
Novartis Investigative Site
mi
from
Meridian, ID
Efficacy and Safety Study of QVA149 in COPD Patients
A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation
Status: Enrolling
Updated: 11/30/2017
Novartis Investigative Site
mi
from
Meridian, ID
Click here to add this to my saved trials
The Therapeutic Workplace Initiation Study
The Therapeutic Workplace Initiation Study
Status: Enrolling
Updated:  12/1/2017
The Center for Learning and Health
mi
from
Baltimore, MD
The Therapeutic Workplace Initiation Study
The Therapeutic Workplace Initiation Study
Status: Enrolling
Updated: 12/1/2017
The Center for Learning and Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Mortality
Status: Enrolling
Updated:  12/4/2017
Arizona Respiratory Center
mi
from
Tucson, AZ
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
Serum Inflammatory Biomarkers as Predictors of COPD Morbidity and Mortality
Status: Enrolling
Updated: 12/4/2017
Arizona Respiratory Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated:  12/7/2017
City of Hope National Medical Center
mi
from
Duarte, CA
Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Status: Enrolling
Updated: 12/7/2017
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials